Federal contractor · WORCESTER, MA

MICROBIOTIX, INC.

MICROBIOTIX, INC. received $3.8M in federal contract obligations in FY2026, on 2 awards (−33% vs FY2025). Since FY2018: $18.6M. Its largest customer was National Institutes of Health ($3.8M). It also received $2.2M in federal grants and other assistance in FY2026.

Obligations · FY2026
$3.8M
New awards
2
Sole-source
0.0%
Single offer
0.0%
UEI
SCNKBDM341T1
Small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 713.4KFY2018
  2. 863.7KFY2019
  3. 1.4MFY2020
  4. 552.7KFY2021
  5. 299.6KFY2022
  6. 2.9MFY2023
  7. 2.5MFY2024
  8. 5.6MFY2025
  9. 3.8MFY2026

Top buying agencies

Obligations in FY2026.

  1. National Institutes of Health$3.8M100%
    2 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Research & development$3.8M100%

Where the work was performed

  1. Worcester County, MA$3.8M100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition0.0%
    US 39% · $0
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions0.0%
    US 8.8% · $0
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. TO DEVELOP THE PPZ SERIES OF SMALL MOLECULE PAN-FILOVIRUS ENTRY INHIBITORS THROUGH LEAD OPTIMIZATION, SELECTION OF A PRECLINICAL CANDIDATE, AND IND-ENABLING PRECLINICAL STUDIES.$8.8M
    National Institutes of Health· Worcester County, MA· Research & development· Oct 31, 2022 – Aug 21, 2026· 75N93023C00001
  2. TO DEVELOP PHENOXYACETAMIDE T3SS INHIBITORS AS ADJUNCTIVE AGENTS TO ANTIBACTERIAL THERAPY FOR MDR P. AERUGINOSA INFECTIONS.$7.3M
    National Institutes of Health· Worcester County, MA· Research & development· Jun 29, 2020 – Aug 26, 2026· 75N93020C00019

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

MICROBIOTIX, INC. received $2.2M in federal assistance in FY2026, on 5 actions (0 new awards), −38% vs FY2025. Its largest program was 93.855 · Allergy and Infectious Diseases Research ($1.6M).

Assistance · FY2026
$2.2M
New awards
0
Actions
5
Since FY2021
$17.2M

Assistance by fiscal year

  1. 7MFY2021
  2. 2.3MFY2022
  3. 1.6MFY2023
  4. 586.7KFY2024
  5. 3.6MFY2025
  6. 2.2MFY2026

By type

  1. Grants$2.2M100%

Top programs

  1. 93.855 · Allergy and Infectious Diseases Research$1.6M70%
  2. 93.867 · Vision Research$669.9K30%

Awarding agencies

  1. National Institutes of Health$2.2M100%
    Department of Health and Human Services

Largest awards

  1. DISCOVERY OF BUNYAVIRAL ENDONUCLEASE INHIBITORS FOR ANTI VIRAL - ABSTRACT SEGMENTED NEGATIVE-SENSE, SINGLE-STRANDED RNA VIRUSES (SNSVS)…$1.9M
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· May 16, 2025 – May 19, 2026· R42AI165102
  2. TRANSLATIONAL STUDIES TO ADVANCE FILOCICLOVIR TO IND SUBMISSION FOR THE TREATMENT OF ADENOVIRAL CONJUNCTIVITIS AND ACUTE…$1.3M
    93.867 · Vision Research· National Institutes of Health· Project grant· Dec 16, 2024 – Jan 29, 2026· R33EY036947
  3. PROOF OF CONCEPT EXPERIMENTS FOR T3SS INHIBITORS AGAINST BURN WOUND INFECTIONS - ABSTRACT THE OVERALL GOAL OF THIS PROPOSAL IS TO DEVELOP A…$600K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Apr 12, 2024 – Jul 16, 2026· R41AI183900
  4. NOVEL BENZYL-PIPERIDINE ANTIFUNGAL AGENTS TO TREAT INTRACTABLE MUCORALES INFECTIONS - TITLE: NOVEL BENZYL-PIPERIDINE ANTIFUNGAL AGENTS TO…$599.3K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Sep 20, 2025 – Aug 25, 2026· R41AI195240
  5. DEVELOPMENT OF WELL TOLERATED NOVEL INHIBITORS OF DRUG RESISTANT CMV - CMV OCCURS AS A BENIGN INFECTION IN MOST HUMANS, WITH AN ESTIMATED…$587.9K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Aug 7, 2025 – Aug 3, 2026· R43AI188690

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2021–FY2026.

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

  • Sub-grants: $391.7K (1 subaward)

1 prime

  1. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI$391.7K100%
    NEW YORK, NY · 1 subaward

By fiscal year

  • FY2021: $100K paid out · $201.3K received
  • FY2022: $0 paid out · $268.4K received
  • FY2023: $0 paid out · $547.6K received
  • FY2024: $0 paid out · $1.1M received
  • FY2025: $0 paid out · $173.1K received
  • FY2026: $0 paid out · $391.7K received

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 3, 2026, loaded Oct 3, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

1 company · $100K reported

  1. THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK$100K
    NEW YORK, NY · 1 subaward

Primes that pay it

4 companies · $2.7M reported

  1. TRUSTEES OF DARTMOUTH COLLEGE$1.5M
    HANOVER, NH · 3 subawards
  2. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI$564.8K
    NEW YORK, NY · 2 subawards
  3. TRUSTEES OF BOSTON UNIVERSITY$543.2K
    BOSTON, MA · 5 subawards · Scientific research and development services

Showing the top 3 of each list. Open the profile for potential partners and the full lists.

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 3, 2026, loaded Oct 3, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

  1. UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON$13.1M+271% in FY2026
    GALVESTON, TX · 100% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  2. BARUCH S. BLUMBERG INSTITUTE$10.7M
    DOYLESTOWN, PA · 90% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services
  3. EMINENT SERVICES CORP$10.7M+99% in FY2026
    FREDERICK, MD · 89% of this company's obligations are in markets they both serveNational Institutes of Health · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 3, 2026, loaded Oct 3, 2026.